International Primary Care Respiratory Group (IPCRG)
This sponsor has funded 2 studies across 7 countries.
| EU PAS ID | Status | RMP requirement | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|---|
| 6749 | Finalised | Unspecified | Multi-component assessment systems and predicting future risk in chronic obstructive pulmonary disease | No | No |
| 41519 | Ongoing | Not included in RMP | The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients | Yes | No |
PAS by Risk Management Plan (RMP) requirement
International Primary Care Respiratory Group (IPCRG)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
International Primary Care Respiratory Group (IPCRG)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
International Primary Care Respiratory Group (IPCRG)
7 Study countries specified are the following:
- Greece
- Netherlands
- Portugal
- Spain
- Sweden
- Ukraine
- United Kingdom